“OZEMPIC FACE: THE ROLE OF THE COSMETOLOGIST IN THE PREVENTION AND CORRECTION OF SKIN AND SOFT TISSUE CHANGES
Semaglutide-induced weight loss often results in a marked reduction in fat compartments and subcutaneous adipose tissue, as well as facial muscle atrophy and signs of premature aging, including in younger patients, so it is recommended to timely prescribe patients a number of cosmetic procedures aimed at prevention and correction of these changes.
Abstract
Semaglutide (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. The drug has gained popularity because of its ability to reduce body weight. However, semaglutide-induced weight loss often results in a marked reduction in fat compartments and subcutaneous adipose tissue, as well as facial muscle atrophy and signs of premature aging, including in younger patients. This phenomenon is called “ozempic face”. It is recommended to timely prescribe patients a number of cosmetic procedures aimed at prevention and correction of these changes. In preparation for semaglutide, procedures aimed at changing the quality of the skin are indicated: collagen-stimulating therapy, biorevitalization, phototherapy and radiofrequency exposure. During treatment with the drug, the procedures should improve skin turgor, affect the muscles and ligamentous apparatus and not damage the fat pouches.